ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $414 | -5.7% | 22,378 | +22.1% | 0.00% | -50.0% |
| Q2 2023 | $439 | +27.2% | 18,333 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $345 | +18.2% | 18,333 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $292 | -99.9% | 18,333 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $300,000 | +16.3% | 18,333 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $258,000 | -41.9% | 18,333 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $444,000 | +3.7% | 18,333 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $428,000 | +40.3% | 18,333 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $305,000 | -31.8% | 18,333 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $447,000 | -5.5% | 18,333 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $473,000 | -51.7% | 18,333 | 0.0% | 0.00% | -60.0% |
| Q4 2020 | $980,000 | +29.6% | 18,333 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $756,000 | -15.0% | 18,333 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $889,000 | +14.7% | 18,333 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $775,000 | -1.1% | 18,333 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $784,000 | +18.8% | 18,333 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $660,000 | +34.7% | 18,333 | 0.0% | 0.00% | +33.3% |
| Q2 2019 | $490,000 | -0.4% | 18,333 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $492,000 | +66.2% | 18,333 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $296,000 | -22.3% | 18,333 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $381,000 | +36.1% | 18,333 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $280,000 | -43.5% | 18,333 | -16.9% | 0.00% | -33.3% |
| Q1 2018 | $496,000 | -25.3% | 22,056 | +0.0% | 0.00% | -25.0% |
| Q4 2017 | $664,000 | -17.5% | 22,049 | +3.2% | 0.00% | -33.3% |
| Q3 2017 | $805,000 | +35.1% | 21,370 | 0.0% | 0.01% | +50.0% |
| Q2 2017 | $596,000 | -18.9% | 21,370 | +0.0% | 0.00% | -33.3% |
| Q1 2017 | $735,000 | +19.1% | 21,366 | -0.2% | 0.01% | +20.0% |
| Q4 2016 | $617,000 | -9.4% | 21,405 | -0.1% | 0.01% | -16.7% |
| Q3 2016 | $681,000 | -6.2% | 21,416 | -4.2% | 0.01% | 0.0% |
| Q2 2016 | $726,000 | +21.0% | 22,365 | +4.3% | 0.01% | +20.0% |
| Q1 2016 | $600,000 | -15.3% | 21,451 | +8.0% | 0.01% | -16.7% |
| Q4 2015 | $708,000 | +7.8% | 19,855 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $657,000 | -21.0% | 19,855 | 0.0% | 0.01% | -14.3% |
| Q2 2015 | $832,000 | +8.5% | 19,855 | -15.7% | 0.01% | +16.7% |
| Q1 2015 | $767,000 | +2.7% | 23,540 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $747,000 | -1.3% | 23,540 | -23.0% | 0.01% | 0.0% |
| Q3 2014 | $757,000 | +9.7% | 30,564 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $690,000 | – | 30,564 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |